Longaeva Partners »

Tango Therapeutics shares owned by Longaeva Partners

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $13M 415k 31.26

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Tango Therapeutics

Rtw Investments
BlackRock
FMR
Farallon Capital Management
Boxer Capital Management
Goldman Sachs Group
TCG Crossover Management
Trv Gp Iv
Paradigm Biocapital Advisors
Siren
Vanguard Capital Management
Adage Capital Partners GP
Jupiter Topco
State Street Corporation
Deep Track Capital

View all funds holding Tango Therapeutics